Md. Monirul Islam started his career as a faculty at Khulna University in December 2018. He completed his Master of Pharmacy and Bachelor of Pharmacy at the same university in 2017 and 2014. Mr. Monir joined a reputed Pharmaceutical Company, NIPRO JMI Pharma, right after his undergraduate and served there for one year before getting admitted into Khulna University for a Master’s degree. He joined Bangladesh University at Dhaka as a Lecturer in the Department of Pharmacy in March 2017 and continued till September 2018. As a scientific officer, he spent two months from October 2018 to November 2018 in the Bangladesh Council of Scientific and Industrial Research before joining Khulna University. Mr. Monir's primary research interest is biomolecular target identification for any underlying disease, drug discovery, and drug delivery systems. His lab focuses on exploring small molecules from medicinal plants to develop newer therapeutic interventions for critical and life-threatening diseases that healthcare professionals confront to manage. Having been funded by the Khulna University Research and Innovation Center, he is studying the antitumor activity of nivolumab-conjugated gold nanoparticles against HeLa cells. His research also highlights in silico drug design that received the ICT Division special grant for developing Molecular Modeling facilities. His research arenas now extend to discovering new drug candidates for diabetes management. His long-term objective is to galvanize cutting-edge research in pharmaceutical sciences through flourishing academic knowledge and research skills.